International critical care hospital pharmacist activities

Intensive Care Medicine

Volumn 34, Issue 3, 2008, Pages 538-542

  LeBlanc, Jaclyn M ^a,b   Seoane Vazquez, Enrique C ^a   Arbo, Trudy C ^b   Dasta, Joseph F ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b Atlantic Health Sciences Corporation   (Canada)

Author keywords

Critical care; Internationality; Pharmacists; Pharmacy service, hospital

Indexed keywords

AMINOGLYCOSIDE; VANCOMYCIN;

ARTICLE; CLINICAL PRACTICE; DEMOGRAPHY; DRUG MONITORING; HEALTH SERVICE; HEALTH SURVEY; HOSPITAL PHARMACY; HUMAN; INFORMATION PROCESSING; INTENSIVE CARE; MAJOR CLINICAL STUDY; PHARMACIST; PHARMACIST ATTITUDE; PROFESSIONAL PRACTICE; TOTAL PARENTERAL NUTRITION; WARD; WEB BROWSER;

CRITICAL CARE; CROSS-CULTURAL COMPARISON; HEALTH CARE SURVEYS; HUMANS; INTERNATIONALITY; INTERNET; MEDICATION THERAPY MANAGEMENT; PHARMACISTS; PHARMACY SERVICE, HOSPITAL;

EID: 43049130394     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0918-2     Document Type: Article

References (15)

1. Dasta J (1982) Critical care therapeutics: a frontier for clinical pharmacy. Drug Int Clin Pharm 16:398-399
2. Dasta J (1996) Evolving role of the pharmacist in the critical care environment. J Clin Anesth 8:99S-102S
3. Dasta J (2006) Critical care. Ann Pharmacother 40:736-737
4. Montazeri M, Cook D (1994) Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med 22:1044-1048
5. Smythe M, Shah P, Spiteri T, Lucarotti R, Begle R (1998) Pharmaceutical care in medical progressive care patients. Ann Pharmacother 32:294-299
6. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, Bates DW (1999) Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 282:267-270
7. Dooley M, Allen K, Doecke C, Galbraith K, Taylor G, Bright J, Carey D (2004) A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Brit J Clin Pharmacol 57:513-521
8. Kane S, Weber R, Dasta J (2003) The impact of critical care pharmacists on enhancing patient outcomes. Int Care Med 29:691-698
9. Razi Z, Latif S, Shamim R (2002) Establishing clinical pharmacy services in a Pakistani intensive care unit. Am J Health Syst Pharm 59:1888-1889
10. Zaidi S, Hassan Y, Postma M, Ng S (2003) Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital. Pharm World Sci 25:299-302
11. Rudis M, Brandl K (2000) Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Crit Care Med 28:3746-3750
12. Timmins A (2000) The contribution of the intensive care pharmacist in the United Kingdom. Pharm J 265:341-344
13. MacLaren R, Devlin J, Martin S, Dasta J, Rudis M, Bond C (2006) Critical care pharmacy services in United States hospitals. Ann Pharmacother 40:612-618
14. Dasta J, Segal R, Cunningham A (1989) National survey of critical-care pharmaceutical services. Am J Hosp Pharm 46:2308-2312
15. LeBlanc J, Seoane-Vazquez E, Dasta J (2007) Global report of hospital pharmacist activities. Am J Health Syst Pharm 64:1748-1755